Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies. Recio F, Scalise CB, Loar P, Lumish M, et al. Gynecol Oncol 2024;182:63-69.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Recio F, Scalise CB, Loar P, Lumish M, et al. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies. Gynecol Oncol 2024;182:63-69.
PMID: 38262240